Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators

Details for Australian Patent Application No. 2008326360 (hide)

Owner Abbott Laboratories

Inventors Ji, Jianguo; Lee, Chih-Hung; Sippy, Kevin B.; Gopalakrishnan, Murali; Li, Tao

Agent Spruson & Ferguson

Pub. Number AU-A-2008326360

PCT Pub. Number WO2009/067579

Priority 60/989,538 21.11.07 US

Filing date 20 November 2008

Wipo publication date 28 May 2009

International Classifications

C07D 451/04 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 451/06 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/067579 Priority application(s): WO2009/067579

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008326381-Biaryl PDE4 inhibitors for treating inflammation

2008326359-New vitamin D receptor activators and methods of making